![David Fuller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fuller
Hoofd Techniek/Wetenschap/O&O bij
DIMERIX LIMITED
Profiel
David Fuller is Chairman at EpiAxis Therapeutics Pty Ltd. since 2020.
Dr. Fuller is Chief Medical Officer at Dimerix Ltd. since 2023.
Former roles include Non-Executive Director at Linear Clinical Research Ltd., Non-Executive Director at AdAlta Ltd. from 2020 to 2026, and Chief Medical Officer at Racura Oncology Ltd. from 2021 to 2022.
Education includes an undergraduate degree from The University of Sydney.
Actieve functies van David Fuller
| Bedrijven | Functie | Begin |
|---|---|---|
| DIMERIX LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-10-2023 |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Voorzitter | 01-07-2020 |
Eerdere bekende functies van David Fuller
| Bedrijven | Functie | Einde |
|---|---|---|
| ADALTA LIMITED | Directeur/Bestuurslid | 17-04-2026 |
| RACURA ONCOLOGY LTD | Hoofd Techniek/Wetenschap/O&O | 11-11-2022 |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Directeur/Bestuurslid | - |
Linear Clinical Research Ltd. | Directeur/Bestuurslid | - |
Opleiding van David Fuller
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
 Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
 AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
